|
⚲
|
| Keyboard |
| Adams Street Partners LLC
✚
|
|
|---|---|
| CRD # | 109358 |
| SEC # | 801-58169 |
| CIK # | 0001193586, 0002137923, 0901032026 |
| AUM | 66.49 B (2026-06-17) |
| Employees | 318 (60% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 312-553-7890 |
| Address | One North Wacker Drive, Suite 2700 Chicago, IL 60606-2823 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| In the News | |
|---|---|
| Sun, 24 May 2026 | Adams Street Partners Exits Its 223,000-Share Paymentus (PAY) Position for $5.9 Million — Yahoo Finance |
| Fri, 01 May 2026 | Adams Street Partners on tapping the VC pipeline to AI — Private Equity International | PEI |
| Wed, 22 Apr 2026 | Adams Street Partners closes sixth co-investment fund at $2.5bn — Private Equity Insights |
| Tue, 14 Apr 2026 | Adams Street Partners holds $7.5bn final close — Private Debt Investor |
| Mon, 13 Apr 2026 | Adams Street Partners: $7.5 Billion Raised For Third Private Credit Platform — Pulse 2.0 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Billiontoone Inc | 135.1 | ||
| GP Investments Acquisition Corp | 77.3 | ||
| Corvus Pharmaceuticals Inc | 47.9 | ||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Adams Street 2026 Direct Growth Equity Fund LP | [2026-03-31] | 0.2 M | |
| Filed 2025-12-19 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| PE | Adams Street 2026 Global Fund LP | [2026-03-31] | 168.5 M | |
| Filed 2025-12-19 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| PE | Adams Street 2026 Non-US Fund LP | [2026-03-31] | 0.2 M | |
| Filed 2025-12-19 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| PE | Adams Street 2026 US Fund LP | [2026-03-31] | 0.3 M | |
| Filed 2025-12-19 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| PE | Adams Street APF Fund LP | 2026-03-31 | 70.9 M | |
| PE | Adams Street Asia Venture Mandate Fund LP | 2026-03-31 | 200.3 M | |
| PE | Adams Street GSF 8 Select Fund LP | [2026-03-31] | 62.0 M | |
| Filed 2025-11-05 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| PE | Adams Street Headwaters Fund LP | 2026-03-31 | 200.5 M | |
| PE | Adams Street Lake LaSalle Fund III LP | 2026-03-31 | 150.2 M | |
| PE | Adams Street PEP Asia Fund 2025 LP | 2026-03-31 | 13.1 M | |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 373 | 60.9 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.9 |
| (j) Other investment advisers | 0 | 4.4 |
| (k) Insurance companies | 0 | 0.1 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.1 |
| (n) Other | 0 | 0.0 |
| Total | 405 | 66.5 |
| By Discretionary | ||
| Discretionary | 364 | 58.7 |
| Non-Discretionary | 41 | 7.8 |
| Total | 405 | 66.5 |
| By Non-United States Persons | ||
| Non-United States Persons | 18.5 | |
| United States Persons | 48.0 | |
| Total | 405 | 66.5 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| James Walker | Executive Officer | 260 | 12 | |
| Kevin Callahan | Executive Officer | 82 | 3 | |
| Michael Kurlander | Executive Officer | 64 | 3 | |
| Michael Jacobs | Executive Officer | 23 | 3 | |
| Adams Street Partners LLC | Director, Executive Officer | 207 | 2 | |
| Jeffrey Diehl | Executive Officer | 198 | 2 | |
| Kevin O'Donnell | Executive Officer | 166 | 2 | |
| Jeffrey Akers | Director, Executive Officer | 157 | 2 | |
| J Fencik | Executive Officer | 150 | 2 | |
| Miguel Gonzalo | Executive Officer | 130 | 2 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001193586] | |
| 3 | [0001193586] | |
| 4 | [0001193586] | |
| SC 13D | [0001193586] | |
| SC 13G | [0001193586] | |
| 3 | [0002137923] | |
| 4 | [0002137923] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $22.0B |
| Clients | 2 (18 non-US) |
| Serves | Institutional |
| Fund Types | Private Equity |
| Related People Network |
|---|
| 71 people file Form D offerings alongside this firm's people, tied to 1 other firms through shared filers. |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rimini Street Inc RMNI
Restricted Stock Unit · derivative
|
2025-06-04 | Grant | 55,727 | $0.00 | |
|
Rimini Street Inc RMNI
Restricted Stock Unit · derivative
|
2025-06-03 | Option exercise | 65,335 | $0.00 | |
|
Rimini Street Inc RMNI
Common Stock
|
2025-06-03 | Option exercise | 65,335 | ||
|
Rimini Street Inc RMNI
Restricted Stock Unit · derivative
|
2024-06-06 | Grant | 65,335 | $0.00 | |
|
Rimini Street Inc RMNI
Restricted Stock Unit · derivative
|
2024-06-05 | Option exercise | 40,178 | $0.00 | |
|
Rimini Street Inc RMNI
Common Stock
|
2024-06-05 | Option exercise | 40,178 | ||
|
Rimini Street Inc RMNI
Restricted Stock Unit · derivative
|
2023-06-07 | Grant | 40,178 | $0.00 | |
|
Rimini Street Inc RMNI
Common Stock
|
2023-06-06 | Option exercise | 45,918 | ||
|
Rimini Street Inc RMNI
Restricted Stock Unit · derivative
|
2023-06-06 | Option exercise | 45,918 | $0.00 | |
|
Corvus Pharmaceuticals Inc CRVS
Stock Option (Right to Buy) · derivative
|
2022-08-11 | Grant | 15,000 | $0.00 | |
|
Rimini Street Inc RMNI
Restricted Stock Unit · derivative
|
2022-06-01 | Grant | 27,522 | $0.00 | |
|
Rimini Street Inc RMNI
Restricted Stock Unit · derivative
|
2022-05-31 | Option exercise | 27,565 | $0.00 | |
|
Rimini Street Inc RMNI
Common Stock
|
2022-05-31 | Option exercise | 27,565 | ||
|
Corvus Pharmaceuticals Inc CRVS
Stock Option (Right to Buy) · derivative
|
2021-09-09 | Grant | 15,000 | $0.00 | |
|
Icosavax Inc ICVX
Series B-1 Preferred Stock · derivative
|
2021-08-02 | Conversion | 114,843 | ||
|
Icosavax Inc ICVX
Series B-1 Preferred Stock · derivative
|
2021-08-02 | Conversion | 309,321 | ||
|
Icosavax Inc ICVX
Series A-1 Preferred Stock · derivative
|
2021-08-02 | Conversion | 935,985 | ||
|
Icosavax Inc ICVX
Common Stock
|
2021-08-02 | Conversion | 352,037 | $0.00 | |
|
Icosavax Inc ICVX
Series A-1 Preferred Stock · derivative
|
2021-08-02 | Conversion | 2,013,269 | ||
|
Icosavax Inc ICVX
Common Stock
|
2021-08-02 | Conversion | 948,188 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
Lexington Partners LP
✚
|
NY | 79.27 B |
|
Brookfield Asset Management PIC Adviser Private Equity LP
✚
|
73.82 B | |
|
Stone Point Capital LLC
✚
|
CT | 67.63 B |
|
I Squared Capital Advisors US LLC
✚
|
FL | 60.09 B |
|
Valor Management LLC
✚
|
IL | 59.32 B |
|
AlpInvest US Holdings LLC
✚
|
NY | 57.66 B |
|
SB Investment Advisers US Inc
✚
|
CA | 53.47 B |
|
Capital International Inc
✚
|
CA | 51.92 B |
|
Genstar Capital Management LLC
✚
|
CA | 51.26 B |
|
GTCR LLC
✚
|
IL | 48.64 B |